- Home
- RGS vs AVTX Comparison
RGS vs AVTX Comparison
Compare RGS & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- AVTX
- Stock Information
- Founded
- RGS 1922
- AVTX 2011
- Country
- RGS United States
- AVTX United States
- Employees
- RGS N/A
- AVTX N/A
- Industry
- RGS Other Consumer Services
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- AVTX Health Care
- Exchange
- RGS Nasdaq
- AVTX Nasdaq
- Market Cap
- RGS 54.2M
- AVTX 57.4M
- IPO Year
- RGS 1991
- AVTX 2015
- Fundamental
- Price
- RGS $19.68
- AVTX $8.99
- Analyst Decision
- RGS
- AVTX Strong Buy
- Analyst Count
- RGS 0
- AVTX 7
- Target Price
- RGS N/A
- AVTX $31.00
- AVG Volume (30 Days)
- RGS 12.6K
- AVTX 254.3K
- Earning Date
- RGS 08-27-2025
- AVTX 08-07-2025
- Dividend Yield
- RGS N/A
- AVTX N/A
- EPS Growth
- RGS N/A
- AVTX N/A
- EPS
- RGS 41.20
- AVTX 3.09
- Revenue
- RGS $199,112,000.00
- AVTX $441,000.00
- Revenue This Year
- RGS N/A
- AVTX N/A
- Revenue Next Year
- RGS N/A
- AVTX N/A
- P/E Ratio
- RGS $0.52
- AVTX $2.69
- Revenue Growth
- RGS N/A
- AVTX N/A
- 52 Week Low
- RGS $15.00
- AVTX $3.39
- 52 Week High
- RGS $29.28
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- RGS 37.00
- AVTX 74.32
- Support Level
- RGS $18.20
- AVTX $7.87
- Resistance Level
- RGS $19.99
- AVTX $8.79
- Average True Range (ATR)
- RGS 0.77
- AVTX 0.74
- MACD
- RGS -0.10
- AVTX 0.15
- Stochastic Oscillator
- RGS 31.07
- AVTX 75.63
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).